Salvetti Andrea, Ferrari Vincenzo, Garofalo Remigio, Gazzaniga Pietro, Guerroni Alessandro, Metrucci Antonio, Sessa Aurelio, Severi Maria Loretta, Nati Giulio, Ruggeri Mauro, Rossi Alessandro, Cappellari Laura, Gopala Kusuma, Tosatto Roberta, Simone Benedetto
Investigator site, Piazza Ponchielli 1, Toscana, Grosseto, GR 58100, Italy.
Investigator site, Via Terranova 2, Puglia, Parabita, LE 73052, Italy.
Prev Med Rep. 2019 Apr 24;14:100882. doi: 10.1016/j.pmedr.2019.100882. eCollection 2019 Jun.
Herpes zoster (HZ) mainly affects older adults and immunocompromised individuals and is usually characterized by a unilateral painful skin rash. Its most common complication, postherpetic neuralgia (PHN), may cause chronic debilitating pain lasting for months or years. This study (ClinicalTrials.gov Identifier: NCT01772160) aimed to estimate the HZ incidence and the proportion of HZ patients with PHN in the Italian population aged 50 years or older. From 2013 to 2016, HZ-patients were recruited when presenting with acute HZ at 75 reporting general practitioners in Italy, covering 43,875 persons aged ≥50 years. PHN was defined as 'worst pain' rated ≥ 3 on the Zoster Brief Pain Inventory persisting or appearing over 90 days after rash onset. The overall HZ incidence rate per 1000 person-years (PY) was estimated as 6.46 (95% confidence interval [CI]: 5.99-6.95), increasing with age to 9.12/1000 PY (95% CI: 7.50-10.99) in 75-79 year-olds. Among 391 HZ-patients who completed the study, the overall proportion with PHN was 10.23% (95% CI: 7.41-13.67) and the highest proportion was 15.56% (95% CI: 6.49-29.46) for the 75-79 year-olds. Among the 128 patients (32.7%) who reported at least one pre-existing medical condition, 35.9% reported diabetes mellitus and 32.0% reported emotional problems, stress or depression. The study confirms previous findings that HZ and PHN cause an important clinical burden in older Italian adults. It also confirmed the age-related increasing risk of HZ and PHN.
带状疱疹(HZ)主要影响老年人和免疫功能低下者,通常表现为单侧疼痛性皮疹。其最常见的并发症,带状疱疹后神经痛(PHN),可能导致持续数月或数年的慢性衰弱性疼痛。本研究(ClinicalTrials.gov标识符:NCT01772160)旨在估计意大利50岁及以上人群带状疱疹的发病率以及带状疱疹后神经痛患者在带状疱疹患者中的比例。2013年至2016年期间,意大利75名报告的全科医生招募了出现急性带状疱疹的患者,覆盖43875名年龄≥50岁的人。PHN被定义为在带状疱疹简明疼痛量表上“最严重疼痛”评分≥3分,且在皮疹发作后持续或出现超过90天。每1000人年(PY)的总体带状疱疹发病率估计为6.46(95%置信区间[CI]:5.99 - 6.95),在75 - 79岁人群中随年龄增长至9.12/1000 PY(95% CI:7.50 - 10.99)。在完成研究的391名带状疱疹患者中,PHN的总体比例为10.23%(95% CI:7.41 - 13.67),75 - 79岁人群中比例最高,为15.56%(95% CI:6.49 - 29.46)。在报告至少一种既往疾病的128名患者(32.7%)中,35.9%报告患有糖尿病,32.0%报告有情绪问题、压力或抑郁。该研究证实了先前的发现,即带状疱疹和带状疱疹后神经痛给意大利老年成年人带来了重要的临床负担。它还证实了带状疱疹和带状疱疹后神经痛与年龄相关的风险增加。